Skip to search form
Skip to main content
Semantic Scholar
All Fields
All Fields
Art
Biology
Business
Computer Science
Chemistry
Economics
Engineering
Environmental Science
Geography
Geology
History
Materials Science
Mathematics
Medicine
Philosophy
Physics
Political Science
Psychology
Sociology
FAQ
Contact Us
•
Sign In
Create Free Account
Secondary Central Nervous System Lymphoma
A non-Hodgkin or Hodgkin lymphoma that has metastasized to the central nervous system following the initial presentation in another nodal or…
Expand
National Institutes of Health
Watch Topic
Related topics
Related topics
13 relations
Atypical lymphocyte
Central Nervous System
Hematopoietic and Lymphoid Cell
Hematopoietic and Lymphoid Tissue
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Secondary central nervous system lymphoma: spectrum of morphological MRI appearances
Hana Malíková
,
Miroslava Burghardtova
,
Eva Koubska
,
Václav Mandys
,
Tomáš Kozák
,
J Weichet
Neuropsychiatric disease and treatment
2018
Background Secondary central nervous system lymphoma (SCNSL) is a rare and aggressive disease, which is defined as secondary…
Expand
Is this relevant?
2017
2017
Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high‐dose methotrexate, and R‐DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2…
Jeanette K. Doorduijn
,
Gustaaf W. van Imhoff
,
+11 authors
Jacoline E. C. Bromberg
Hematological oncology
2017
The prognosis of central nervous system (CNS) relapse of systemic non-Hodgkin lymphoma is poor with 1-year survival historically…
Expand
Is this relevant?
2017
2017
Secondary CNS lymphoma: the poisoned needle in the haystack.
Andrés José María Ferreri
Annals of oncology : official journal of the…
2017
Is this relevant?
2016
2016
Treatment of patients with secondary central nervous system lymphoma with high-dose busulfan/thiotepa-based conditioning and autologous stem cell transplant.
Danielle H. Oh
,
Neil Sun Chua
,
Lesley Street
,
Douglas A Stewart
Leukemia & lymphoma
2016
Although the survival rates are extremely low for patients with secondary central nervous system lymphoma (SCNSL) treated with…
Expand
Is this relevant?
2016
2016
Phase I study of single agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).
Christian Grommes
,
Thomas Kaley
,
+4 authors
Lisa M DeAngelis
2016
2046Background: PCNSL is an aggressive primary brain tumor. Outcome and treatment options are poor for patients with recurrent…
Expand
Is this relevant?
2016
2016
Involvement of cranial nerves in a patient with secondary central nervous system lymphoma
Roberta Dantas Azevedo
,
Fabiano Reis
,
Marcia Torresan Delamain
,
Carmino Antônio de Souza
Revista brasileira de hematologia e hemoterapia
2016
Neurolymphomatosis (NL) is a rare disease that can be caused by T cell, B cell or natural killer cell (NK) lymphomas, but most…
Expand
Is this relevant?
2015
2015
Advances in the Treatment of Secondary CNS Lymphoma.
Norbert Schmitz
,
H S Wu
Journal of clinical oncology : official journal…
2015
Secondary involvement of the CNS by diffuse large B-cell lymphoma (DLBCL) occurs in less than 1% to more than 10% of patients…
Expand
Is this relevant?
2011
2011
Clinical features and treatment outcomes of isolated secondary central nervous system lymphomas in Miyazaki Prefecture
Noriaki Kawano
,
Hidenobu Ochiai
,
+19 authors
Kazuya Shimoda
International Journal of Clinical Oncology
2011
BackgroundSecondary central nervous system lymphoma (SCNSL) without extra-central nervous system (CNS) involvement is…
Expand
Is this relevant?
Review
2010
Review
2010
Treatment and prevention of secondary CNS lymphoma.
Seema Nagpal
,
Michael J. Glantz
,
Lawrence Recht
Seminars in neurology
2010
Central nervous system (CNS) involvement in non-Hodgkin lymphoma is a serious, potentially preventable complication that can…
Expand
Is this relevant?
Review
2005
Review
2005
Secondary central nervous system lymphoma: risk factors and prophylaxis.
Silvia Montoto
,
T. Andrew Lister
Hematology/oncology clinics of North America
2005
Patients diagnosed with diffuse large-cell lymphoma, peripheral T-cell non-Hodgkin's lymphoma or mantle cell lymphoma (either…
Expand
Is this relevant?